Pyc Therapeutics Stock Probability Of Bankruptcy

PYC Stock   1.40  0.05  3.45%   
PYC Therapeutics' chance of distress is over 60% at this time. It has an above-average odds of going through some form of financial hardship in the next 2 years. Probability of financial unrest prediction helps decision makers evaluate PYC Therapeutics' chance of financial distress in relation to its going-concern outlook and evaluation. All items used in analyzing the odds of distress are taken from the PYC balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PYC Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
  

PYC Therapeutics Company probability of financial unrest Analysis

PYC Therapeutics' Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current PYC Therapeutics Probability Of Bankruptcy

    
  Over 68%  
Most of PYC Therapeutics' fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PYC Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of PYC Therapeutics probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting PYC Therapeutics odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of PYC Therapeutics financial health.
Please note, there is a significant difference between PYC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if PYC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PYC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, PYC Therapeutics has a Probability Of Bankruptcy of 68%. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The probability of bankruptcy for all Australia stocks is notably lower than that of the firm.

PYC Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PYC Therapeutics' direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PYC Therapeutics could also be used in its relative valuation, which is a method of valuing PYC Therapeutics by comparing valuation metrics of similar companies.
PYC Therapeutics is currently under evaluation in probability of bankruptcy category among its peers.

PYC Therapeutics Main Bankruptcy Drivers

201920202021202220232024 (projected)
Net Debt(6.4M)(17.7M)(28.2M)(15.3M)(65.8M)(62.5M)
Total Current Liabilities705.6K3.3M4.4M8.4M9.1M9.6M
Total Assets31.5M57.9M45.4M37.2M91.2M95.8M
Total Current Assets25.6M51.8M39.2M31.9M85.6M89.9M
Total Cash From Operating Activities(5.7M)(11.8M)(21.8M)(24.4M)(38.6M)(36.7M)

PYC Fundamentals

About PYC Therapeutics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze PYC Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PYC Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PYC Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for PYC Stock Analysis

When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.